Internship

AI Micro Tools Developer Intern

Posted on 1/15/2025

Zoetis

Zoetis

5,001-10,000 employees

Compensation Overview

$16 - $40.30Hourly

+ $16.00 for Associate-level degree + $20.00 for Undergraduate-level degree + $32.50 for Graduate-level degree + $36.00 for Doctorate-level degree + $17.00 for Associate-level degree in specific states + $22.00 for Undergraduate-level degree in specific states + $36.40 for Graduate-level degree in specific states + $40.30 for Doctorate-level degree in specific states

Remote in USA

Candidates must possess or obtain authorization to work in the US for Zoetis.

Category
Applied Machine Learning
Natural Language Processing (NLP)
AI & Machine Learning
Required Skills
Python
Data Science
SQL
Java
C/C++
Requirements
  • Currently pursuing a degree in Computer Science, Artificial Intelligence, Data Science, or a related field.
  • Knowledge of AI, Software Development, General Database structure and SQL
  • Good programming skills in languages such as Python, Java, or C++
  • Strong communication, collaboration, and documentation skills
  • Familiarity with AI frameworks and libraries
  • Understanding of the various versions of GPTs (and other models) and Open AI’s APIs
Responsibilities
  • Collaborate with the Veterinary Research and Medicine (VMRD) Engineering team to design, develop, and test micro tools for various AI applications.
  • Engage in an initiative utilizing Neo4J to build a knowledge graph of our vast R&D scientific application capabilities.
  • Assist in the optimization and enhancement of existing AI tools to improve performance and efficiency.
  • Conduct research on the latest AI technologies and methodologies to integrate into our projects.
  • Participate in code reviews and contribute to the overall improvement of code quality.
  • Document development processes, tools, and methodologies for future reference.
  • Provide support in troubleshooting and resolving technical issues related to AI tools.
Desired Qualifications
  • Experience in Neo 4J, Webstacks, React or PHP is a plus.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Parsippany-Troy Hills, New Jersey

Founded

1952

Simplify Jobs

Simplify's Take

What believers are saying

  • Zoetis benefits from the growing animal health market, projected to reach $112.33 billion by 2030.
  • The rise of pet insurance boosts demand for Zoetis' advanced veterinary services and products.
  • Zoetis' focus on AI integration in diagnostics aligns with accelerating industry trends.

What critics are saying

  • Emerging biotech firms in animal health could threaten Zoetis' market share.
  • Departure of key legal personnel may cause transitional challenges in compliance areas.
  • Competitors' rapid digital solutions advancement may outpace Zoetis' technological offerings.

What makes Zoetis unique

  • Zoetis is the world's leading animal health company, showcasing strong market leadership.
  • The company launched Vetscan OptiCell, a screenless hematology analyzer, in January 2025.
  • Zoetis collaborates with Colorado State University to advance sustainable animal production research.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Company News

MarketBeat
Feb 27th, 2025
World Equity Group Inc. Invests $342,000 in Zoetis Inc. (NYSE:ZTS)

World Equity Group Inc. invests $342,000 in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Feb 22nd, 2025
Tandem Investment Advisors Inc. Invests $32.19 Million in Zoetis Inc. (NYSE:ZTS)

Tandem Investment Advisors Inc. invests $32.19 million in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Jan 17th, 2025
Miracle Mile Advisors LLC Makes New $272,000 Investment in Zoetis Inc. (NYSE:ZTS)

Miracle Mile Advisors LLC makes new $272,000 investment in Zoetis Inc. (NYSE:ZTS).

TipRanks
Jan 13th, 2025
Zoetis Highlights Growth at J.P. Morgan Conference

Zoetis announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference, showcasing its exemplary 2024 performance and strategic growth initiatives.

Stock Titan
Jan 7th, 2025
Is Zoetis Inc. (NYSE: ZTS) Overvalued? Or Is It Worth Buying Now?

BetterInvesting Magazine has selected Zoetis (NYSE: ZTS) as its 'Stock to Study' for the March 2025 issue, suggesting the stock warrants further investigation by investors.

INACTIVE